Chloride Channels - New Targets for the Prevention of Stroke

被引:11
|
作者
Du, Yan-Hua [1 ]
Guan, Yong-Yuan [1 ]
机构
[1] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Pharmacol, Cardiac & Cerebral Vasc Res Ctr, Guangzhou 510080, Guangdong, Peoples R China
基金
中国国家自然科学基金;
关键词
CIC-3; TMEM16A; cerebral vascular remodeling; stroke; proliferation; apoptosis; inflammation; BLOOD-PRESSURE REDUCTION; CELL-VOLUME REGULATION; OF-NEUROLOGY AFFIRMS; ACTIVATED CL-CURRENT; SMOOTH-MUSCLE-CELLS; FACTOR-KAPPA-B; ISCHEMIC-STROKE; NADPH OXIDASE; VASCULAR EVENTS; STATIN THERAPY;
D O I
10.2174/1570161112666141014145040
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Stroke is a leading cause of morbidity and mortality worldwide. It has been generally accepted that cerebrovascular remodeling during hypertension is one of the major contributors to the increased risk of stroke. Volume-regulated Cl- channel (VRCC) and calcium-activated Cl- channel (CaCC) are the two predominant types of Cl- channels in cerebral vascular smooth muscle cells (VSMC). Recent studies have demonstrated that ClC-3, a member of the voltage-gated ClC Cl- channel family, is the molecular candidate for VRCC in VSMC. And TMEM16A, a member of anoctamin family, is responsible for the native CaCC of VSMC in brain vessels. It has been shown that VRCC activity is enhanced but CaCC activity is decreased in cerebral VSMC, paralleling the severity of cerebrovascular remodeling induced by hypertension. In the present review, we will highlight the recent findings regarding the important roles of these two channels in VSMC proliferation, apoptosis, cell cycle regulation, vascular inflammation, reactive oxygen species production and cerebrovascular remodeling during the development of hypertension. In addition, the relationship between VRCC and clinical used agents for stroke prevention, such as statins, will be discussed. These findings suggest that Cl- channels may be potential new targets for the prevention of stroke.
引用
收藏
页码:441 / 448
页数:8
相关论文
共 50 条
  • [31] New Findings in Stroke Prevention and Treatment
    Weimar, C.
    Weber, R.
    Hajjar, K.
    Frank, B.
    Diener, H-C.
    AKTUELLE NEUROLOGIE, 2011, 38 (08) : 403 - 413
  • [32] A promising new anticoagulant for stroke prevention
    Sarah A. Spinler
    Nature Reviews Cardiology, 2010, 7 : 10 - 11
  • [33] Stroke prevention: what's new?
    Gerraty, RP
    INTERNAL MEDICINE JOURNAL, 2003, 33 (04) : 177 - 181
  • [34] TICLOPIDINE - NEW OPTION FOR STROKE PREVENTION
    SILA, CA
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 1991, 58 (02) : 113 - 114
  • [35] New genetic concepts and stroke prevention
    Auburger, G
    CEREBROVASCULAR DISEASES, 1998, 8 : 28 - 32
  • [36] New therapeutic approaches in stroke prevention
    Gil-Núñez, AC
    REVISTA DE NEUROLOGIA, 2002, 35 (09) : 801 - 804
  • [37] New oral anticoagulants in the prevention of stroke
    Jarzabek, Konrad
    Bakowski, Dawid
    Wozakowska-Kaplon, Beata
    MEDICAL STUDIES-STUDIA MEDYCZNE, 2013, 29 (03) : 264 - 266
  • [38] A new approach to stroke prevention in Russia
    Feigin V.L.
    Varakin Y.Y.
    Kravchenko M.A.
    Piradov M.A.
    Tanashyan M.M.
    Gnedovskaya E.V.
    Stakhovskaya L.V.
    Shamalov N.A.
    Krishnamurthi R.
    Bhattacharjee R.
    Parmar P.
    Hussein T.
    Barker-Collo S.
    Human Physiology, 2016, 42 (8) : 854 - 857
  • [39] New: Digital Stroke Prevention Guide
    不详
    JOURNAL OF CARDIOVASCULAR NURSING, 2019, 34 (01) : 1 - 1
  • [40] Primary Prevention of Stroke - What is New?
    Sander, D.
    Poppert, H.
    Sander, K.
    Etgen, T.
    AKTUELLE NEUROLOGIE, 2011, 38 (08) : 414 - 427